Q&A: Ireland biopharma leader discusses the nation’s 2022 boost in manufacturing
The Emerald Isle has been of major interest to pharma manufacturers for several decades now, with giants like Pfizer, Novartis, and Bayer calling Ireland home since the 1950s and 1960s.
Ireland returned to the spotlight this year with expansion projects and new construction projects totaling hundreds of millions of Euros, and, most recently, Pfizer’s more than $1.2 billion investment in its manufacturing site at Grange Castle in Dublin, marking Pfizer’s largest expansion investment in Ireland to date.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.